jerusalem id card
DESCRIPTION
Jerusalem ID Card. Key Facts Population 2002: 680,300 Forecast Population in 2020: 946,500 HUJ (80 years): 24,000 students,10,000 graduates 1100 Academics. R&D. THE SHERMAN BUILDING FOR RESEARCH ADMINISTRATION Edmond J.Safra Campus, Givat Ram. ARD Prospecting new Funding sources - PowerPoint PPT PresentationTRANSCRIPT
Jerusalem ID CardJerusalem ID CardKey Facts
•Population 2002: 680,300
•Forecast Population in 2020: 946,500
•HUJ (80 years): 24,000 students,10,000 graduates
1100 Academics
THE SHERMAN BUILDING
FOR RESEARCH ADMINISTRATION
Edmond J.Safra Campus, Givat Ram
R&D
ARD
Prospecting new Funding sources
Distributing Information to Researchers
* controls expenses according to appropriate items
* is responsible for the scientific report
* is responsible for the financial report
RESEARCH PROJECTS IN THE HEBREW UNIVERSITY
YEAR 2003
1, 157 NEW 3,200 IN OPERATION
FLUCTUATION IN RESEARCH FUNDS
72
74
76
78
80
82
84
86
1998/91999/2000
2000/1year
in m
illi
on
s o
f d
oll
ars
76
81
84
2001/2
82.584
2002/3
90
2004
EFFECTIVE ANNUAL RESEARCH INVESTMENT
AT HUJGrant/Centers Funds $ 83 Million
Fellowship $ 14 Million
Salaries $ 103 Million
TOTAL $ 200 Million
30% of all Israeli civilian Research
Research Funds Sources 2003
IndustryGovernmentFoundationsInternalOthers
22.5
18
23.5
108
Social sciences12 %
Medicine22 %
Natural Sciences
29 %
Agriculture21 %
Education5 %
Social Work
2 %
Law1%
Humanities4 %
Business Administration
1 %
Dental Medicine3 %
DISTRIBUTION AMONG FACULTIES 2002/03
INTERNAL RESEARCH GRANTS2002/3
•Support for Basic Research $ 2,400,000
•Support for Applied Research $ 700,000
Total $ 3,100,000
Equipment 1,500,000
Grand Total 4,600,000
ICNC
BIS
Talmud says “The traditions cited by Rabbi Sheshet are not subject to doubt as he is a blind man” (Talmud Yerushalmi, Shabbat 1b).
)()()()( tututMu
Xab
2. Sampled signals
3. Interpreter
4. Robotic
arm
1. Recording
s and telemetry
5. Desired Target
\
USA, Holland, Israel, Denmark
France, UK, Germany
1.5
1.0
0.5
IMPACT RELATIVE TO THE FIELDComputer Sciences, Material Sciences
15 Academics high scientific rank
40 M US $ investment in Heavy equipment-infrastructurein the next 5 years
DECISION
http://nanoscience.huji.ac.il/
The Center for Nanoscience and Nanotechnology
Micha Asscher and Scientific american 2004
boron, carbon, nickel and hydrogen
MOTOR 144o
FUEL
BIOINFORMATICShttp://www.cbc.huji.ac.il/
The Sudarsky Centerfor ComputationalBiology
Distribution of MSc. and PhD. Students in Biotechnology Related Fields, by Institute
Hebrew U
TechnionTel Aviv
Weizmann
Haifa
Ben Gurion
Bar Ilan
(9% )389
(1% )34
(5% )236
(28% )1,246(3% )128
(43% )1,667
(11% )485
Source: Vatat - The Planning and Budgeting Committee
Ben Gurion
0 500 1000 1500 2000
Weizmann
Haifa
Bar Ilan
Tel Aviv
Technion
Hebrew U
MSc. and PhD. Students in Biotechnology Related Fields by Institute )2001(
agriculture
Source: Vatat - The Planning and Budgeting Committee
PRIZESPRIZESEncouraging Excellence in
Research
Birk
Kaye
Abisch
Barenholz
Polonsky
Universities Fuel Israel’s IndustriesUniversities Fuel
Israel’s Industries
Yissum, the Technology Transfer Company (TTC) is responsible for recognizing and managing the IP assets of the Hebrew University in Jerusalem.
Yissum’s mission is to help turn science into tangible products, for society's use and benefit, while generating income for the inventors and the University, to support research and education.1) evaluating projects, 2) patenting new inventions, 3) developing licensing strategies, 4) negotiating licensing agreements, 5) assisting and supporting researchers who wish to establish companies to develop and manufacture products based on their inventions, and 6) coordinating joint research between inventors and industrial partners.
It is general policy that rights to IP resulting from government-sponsored research at universities would be assigned to the universities.The Technology Transfer Process1) Yissum receives innovation disclosures from faculty, staff and students.(HU rules).2) Disclosures are evaluated for their commercial potential.3) The invention is reviewed with the inventor to learn about potential applications.4) Develop a licensing strategy, consider the technical and market risks and decide whether to patent the invention. Yissum can decide not to pursue a commercialization process, the inventor is notified and entitled to apply for a patent independently and at his own expense. The IP however, remains the property of the Hebrew University.
Acquired bureaucratic deficiency syndrome
Material with potential to become a revolutionary medicine for treating AIDS was found in 1996 by Prof. Zeev Trainin, Trainin and his team injected the material into mice that were infected with an AIDS-like disease and the disease disappeared almost in some of the mice. The Industry and Trade Ministry agreed to provide the necessary financing through one of its "high-tech incubator" funds, but the Agriculture Ministry refused to waive its intellectual property rights. Like children, the two ministries squabbled over who owned the rights and in the meantime, the entire testing process came to a halt. Trainin succeeded in interesting an investor from Britain in the drug, but then the Justice Ministry ruled that the Agriculture Ministry could not enter into direct contractual ties with foreign investors
Technology Transfer ServicesDifferent inventions require different approaches and strategies of commercialization, For example, establishing start-up entities and incubator companies vis a vis licensing out IP rights. As part of the commercialization process our assortment of available services includes:
patent applications and enforcement,
legal advice,
negotiation of agreements,
business development and
creating marketing materials.
Royalties distribution
•Until 2001, royalties distribution was as follows :•1/3 – To the Researchers
•1/3 – To Yissum•1/3 – To the HU, as research share )to research
budgets(•As of January 2001, new royalties distribution
formula is used, as follows:•20% - To the Researchers
•40% -To Yissum and the HU•20% - To the HU, as research share )to research
budgets(
No. of Employees
1719
0
5
10
15
20
2001 2004
No. of Employees
January 9, 2005
New Files By Area II
Medicine18%
Pharmacy20%
Dental Medicine7%
Agriculture9%
Chemistry18%
Computers4%
Physics5%
Life Sciences19%
New Files 2004 by Type
1% 7%1%
3%
5%
1%1%
81%
EP UT
EU & US
Israel
PCT
Prov +
Prov + Reg )Israel(
US
US + PCT
http://www.yissum.co.ilfounded 1964
Around 35 companies Ex Libris, HumanEyes Technologies Ltd. • Red Herring' chose MobilEye as top innovative company for 2004,• NovaGali•
AQ10 BIOFUNGICIDE • CHERRY TOMATOES -Cocktail Hybrids• DEXANABINOL • DOXIL • EXELON )rivastigmine tartrate(capsules • RAM ONION• SILKIS The first eye drop which is capable of abolishing
the conjunctival damage in moderate orsevere dry eye symptom
• SUPRA-VIR